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DObjective: Recent advancements in thoracic endovascular aortic repair, such as branched endografts or hybrid
debranching/thoracic endovascular aortic repair, have extended the option of endoluminal therapy into the realm
of the aortic arch. A contemporary assessment of open arch repair to provide long-term data for comparative
analysis for these newer therapies is timely, warranted, and presented in this article.
Methods: Since the inception of our thoracic endovascular aortic repair program in 1993, 721 patients (mean
age of 59.3 years, 68.9% were male) have undergone median sternotomy and open arch reconstruction with
hypothermic circulatory arrest. Extended arch repair was performed in 42.7% with construction of bypasses
to the innominate (296 patients), left carotid (216 patients), and subclavian (75 patients) arteries or elephant
trunk procedures (42 patients). Concomitant aortic valve or aortic root replacement was required in 403 patients,
and root reconstruction was required in 222 patients. Retrograde (641 patients) or antegrade (400 patients) ce-
rebral perfusion was used for neuroprotection during hypothermic circulatory arrest. The operative procedure
was urgent or emergency in 316 patients (43.8%) and included repair of type A dissection in 284 patients
(39.3%). A total of 111 patients (15.4%) had undergone prior cardiac surgery. Primary outcomes in this study
were early and late mortality. Follow-up was 100% complete (mean, 52.6 months).
Results: Thirty-day morbidity included death (36 patients [5%]), stroke (34 patients [4.7%]), and permanent
dialysis (14 patients [1.9%]). Independent predictors of early mortality included advancing age, prolonged by-
pass times, and impaired ejection fraction (all P<.05). Actuarial survival at 10 years was 65%. Independent
predictors of late mortality included advancing age, prolonged lower body circulatory arrest times, and increas-
ing creatinine (all P<.05). By Kaplan–Meier analysis, 10-year survival was significantly reduced after operative
procedures for type A dissection (non–type A 69.1% vs type A 58%, P ¼ .003). Freedom from aortic reopera-
tion (any segment) was 72.6% at 10 years.
Conclusions:Open aortic arch repair can be accomplished with excellent early and late results. These outcomes
provide objective data for comparison and suggest that newer endovascular therapies should be evaluated first in
high-risk groups, such as those with advanced age or impaired renal function before broader application in all
patients. (J Thorac Cardiovasc Surg 2011;141:1417-23)In the century since Sir William Osler remarked that ‘‘there
is no disease more conducive to clinical humility than aneu-
rysm of the aorta,’’ dramatic advances have occurred in the
field of aortic surgery. After the pioneering work by DeBa-
key and colleagues in 1957,1 mortality for arch reconstruc-
tion exceeded 25%, with cause of death often secondary to
neurologic complications. The introduction of deep hypo-
thermic circulatory arrest (HCA) by Griepp and colleagues2e Department of Surgery, University of Michigan Cardiovascular Center, Ann
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The Journal of Thoracic and Carsimplified the operative approach and established a safe
strategy for neuroprotection. Seminal work by Svensson
and associates3 in 1993 demonstrated that these techniques
used in 656 patients could result in death and stroke rates of
10% and 7%, respectively.
Since this landmark report, the introduction of endovas-
cular techniques has revolutionized the therapy of thoracic
aortic disease.4-7 Although initially applied to degenerative
aneurysms confined to the abdominal and descending
thoracic aorta (thoracic endovascular aortic repair
[TEVAR]), recent work has extended the use of this
approach to the arch aorta.4,5 Moreover, in an effort to
reduce the perceived morbidity associated with HCA,
complex extra-anatomic arch vessel bypass and endovascu-
lar repair, that is, debranching procedures and evolving
technology including branched endografts, have extended
TEVAR into the ascending aorta.7,8 The long-term results
of endovascular repairs with or without debranching are still
unclear. It is in this context that a contemporary analysis of
open aortic arch reconstruction focusing on both early anddiovascular Surgery c Volume 141, Number 6 1417
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CI ¼ confidence interval
HCA ¼ hypothermic circulatory arrest
HR ¼ hazard ratio
OR ¼ odds ratio
RCP ¼ retrograde cerebral perfusion
TEVAR ¼ thoracic endovascular aortic repair
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Dlate outcomes is warranted. The study period chosen in this
study reflects the endovascular era at the University of
Michigan, which commenced in 1993.MATERIALS AND METHODS
This study was approved by the institutional review board of the Univer-
sity of Michigan Hospitals (study 2003-0128). Informed consent require-
ments were waived for this study.
A retrospective analysis of data from all patients admitted to the Univer-
sity of Michigan Hospitals from 1993 to 2009 who underwent aortic
replacement was performed. Criteria for entry into the study cohort con-
sisted of (1) approach via a median sternotomy; (2) resection into the
arch aorta (ie, exclusion of open distal anastomosiswithout arch reconstruc-
tion); and (3) use of deep HCA (eg, exclusion of patients undergoing great
vessel bypass for obstructive arch disease). With the use of these inclusion
criteria, 721 consecutive patients constituted the study cohort. A combina-
tion of clinic and hospital records, data from the prospectively collected So-
ciety of Thoracic Surgeons database, imaging studies, and query of the
National Death Index were used to obtain early and long term information.Operative Technique
After median sternotomy and institution of cardiopulmonary bypass,
patients were cooled to 18C nasopharyngeal and bladder temperature
with the maximum temperature gradient between perfusate and body
temperature kept at less than 10C (for both cooling and later rewarming).
During this time, root reconstruction was initiated if necessary. Neuropro-
tective adjuncts, including 25 g mannitol, 1 g methylprednisolone, and 1 g
thiopental, were administered just before institution of HCA. The aorta was
then opened, and the site of distal anastomosis was identified. Retrograde
cerebral perfusion (RCP) was initiated at this time in 641 patients (89%),
with flows of 500 to 800 mL/min titrated to a central venous pressure of 35
mmHg.With proximal hemiarch resection, HCAwith RCP alonewas often
used, and RCP then was discontinued only after reinstitution of cardiopul-
monary bypass to prevent air embolism into the brain. If prolonged HCA
times were expected either on the basis of pathology or the need to extend
arch resection to include great vessels, antegrade cerebral perfusion (ACP)
was used at flow rates of 750 to 1000mL/min titrated to keep the pressure in
the right radial arterial line at 80 mmHg by selective cannulation of the in-
nominate and left carotid arteries or by axillary arterial perfusion with left
carotid artery selective cannulation. In this instance, RCP was then discon-
tinued only after initiation of ACP to prevent air embolism. Rewarming
was initiated after completion of the open distal anastomosis, and flow
was restored to the lower body. Great vessel reimplantation was performed
as an island until 2001, after which each vessel was bypassed separately us-
ing a customized Dacron graft with multiple prefabricated side branches as
previously described. The graft was then sized to an appropriate length, and
a proximal anastomosis was performed. When normothermic, the patient
was weaned from cardiopulmonary bypass as tolerated.1418 The Journal of Thoracic and Cardiovascular SurStatistical Methods
Early outcomes of interest included 30-day or in-hospital rates of mor-
tality, stroke, and renal failure requiring dialysis. The primary late outcome
of interest was survival time and vital status. Early mortality was defined as
that occurring within 30 days of operation or in-hospital death. Late
mortality was defined as that occurring thereafter. Follow-up was 100%
complete up to April 2010 for the primary outcome of late mortality
with a mean of 52.6  39.9 months.
Data were analyzed using SPSS (SPSS Inc, Chicago, Ill). All data are
expressed as mean  standard deviation where applicable. Dichotomous
variables were evaluated using chi-square analysis, and continuous vari-
ables were evaluated using independent t tests. Multivariate models (binary
logistic regression for early outcomes and Cox proportional hazards for late
outcomes) were constructed using a forward conditional process to identify
factors that were independently associated with each of the outcomes of
interest. The factors used in the multivariate analysis included those with
a P value of 0.1 or less on univariate analysis. Results were expressed
with odds ratios (ORs) or hazard ratios (HRs) with 95% confidence
intervals (CIs). Survival was analyzed by Kaplan–Meier methods, with
comparison of survival curves performed with the log-rank test.
RESULTS
The mean age of the study cohort was 59.3  13.9 years
(68.9% were male). Demographics and comorbidities are
listed in Table 1. Indications for intervention included type
A dissection in 284 patients and fusiform aneurysm in 416
patients. Arch repair was performed in the reoperative set-
ting in 111 patients (15.4%); details regarding prior aortic
or cardiac procedures are listed in Table 1. The procedure
was elective in 404 patients (56%), urgent in 128 patients
(17.8%), and emergency in 188 patients (26.1%).
Early Results
Early mortality was seen in 36 patients (5.0%). By mul-
tivariate analysis, older age (P ¼ .001; OR, 1.07; CI,
1.0–1.2), lower ejection fraction (P ¼ .02; OR, 0.97; CI,
0.95–0.99), prolonged cardiopulmonary bypass (P<.0001;
OR, 1.01; CI, 1.007–1.02), and HCA time (P ¼ .02; OR,
1.03; CI, 1.004–1.05) were independently associated with
early mortality. In an attempt to identify whether era of the
operative procedure affected mortality, the entire study pe-
riod was divided into 2 segments: era 1 (1993 to March
2005, n ¼ 316), representing the initial time when endovas-
cular repair (TEVAR) was available only on a limited basis at
the University of Michigan Cardiovascular Center for com-
passionate use or as part of Food and Drug Administration-
sponsored clinical trials; and era 2 (April 2005–2009,
n ¼ 369), when TEVAR was widely available. Although
the mortality rates were different on univariate analysis
(era 1: n ¼ 23, 7.3% vs era 2: n ¼ 13, 3.5%, P ¼ .04), mul-
tivariate analysis did not identify era of operation as an
independent risk factor for death.
Stroke was identified in 34 patients (4.7%). Univariate
predictors of postoperative stroke included the history of
coronary artery disease, chronic obstructive pulmonary dis-
ease, reduced ejection fraction or elevated creatinine, urgent
or emergency operative status, repair of acute type Agery c June 2011
TABLE 1. Patient characteristics
Variable Frequency (%)
Preoperative demographics
Age (y) 59.3  13.9
Male gender 497 (68.9%)
History of tobacco use 377 (52.2%)
Diabetes 51 (7.1%)
Hypertension 464 (64.4%)
Cerebrovascular accident 32 (4.4%)
Mean preoperative creatinine (mg/dL) 1.1  0.7
History of connective tissue disease 22 (3.1%)
Peripheral vascular occlusive disease 67 (9.3%)
Coronary artery disease 145 (20.1%)
Congestive heart failure 88 (12.3%)
Preoperative ejection fraction (%) 52.5%  14%
Elective status of operation 404 (56.0%)
Maximum aortic diameter 5.7  1.2
Diagnosis of acute type A dissection 284 (39.4%)
Prior CABG 29 (4.0%)
Prior aortic valve/root replacement 85 (11.8%)
Prior ascending thoracic aortic repair 23 (3.2%)
Prior descending aortic repair 9 (1.3%)
Intraoperative variables
Aortic valve/root replacement 403 (55.9%)
Aortic valve resuspension 222 (30.1%)
Isolated arch procedure 14 (1.9%)
Extended arch procedure 308 (42.7%)
Innominate artery bypass 296 (41.1%)
Left carotid artery bypass 216 (30.0%)
Left subclavian artery bypass 75 (10.4%)
Descending aortic repair 24 (3.3%)
Elephant trunk procedure 42 (5.8%)
CABG 91 (12.6%)
Mitral valve repair/replacement 21 (2.9%)
Use of RCP 641 (89.0%)
Use of ACP 400 (55.5%)
Cerebral ischemic time (min) 16.6  14.0
Lower body hypothermic arrest time (min) 36.6  15.6
Cardiopulmonary bypass time (min) 216.9  74.3
Crossclamp time (min) 168.2  62.3
CABG, Coronary artery bypass grafting; RCP, retrograde cerebral perfusion; ACP,
antegrade cerebral perfusion.
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section to include left subclavian artery or proximal
descending aorta (all P<.05). Unlike mortality rates, the
occurrence of postoperative stroke was not associated
with era of operation (era 1: n ¼ 14, 4.3% vs era
2: n¼ 20, 5.5%, P¼ .6). By multivariate analysis, indepen-
dent predictors of stroke included history of chronic
obstructive pulmonary disease (P ¼ .01; OR, 3.3; CI, 1.3–
8.2), procedure for type A dissection (P ¼ .003, OR, 4.05;
CI, 1.6–10.1), prolonged HCA time (P ¼ .03; OR, 1.02;
CI, 1.002–1.04), resection into the proximal descending
aorta (P ¼ .03; OR, 4.63; CI, 1.12–19.1), and occurrence
of permanent postoperative dialysis (P ¼ .003; OR, 7.14;
CI, 2.0–26.1).The Journal of Thoracic and CarOther early adverse events included the occurrence of
postoperative renal failure in 42 patients (5.8%), with
permanent dialysis required in only 14 patients (1.9%).
Prolonged ventilation requiring tracheostomy was also ob-
served in 24 patients (3.3%). The median postoperative
length of stay was 8 days (interquartile range, 5–14 days)
and was independent of era of operation (P ¼ .86).
Of the 685 patients surviving the operative period, 104
(15.2%) required admission to a skilled nursing facility
(n ¼ 74) or an inpatient rehabilitation unit (n ¼ 30). At
last follow-up, 47 patients (6.9%) did not return to an
independent lifestyle. Independent predictors of permanent
disability included advancing age (OR, 1.1; P<.0001), his-
tory of CHF (OR, 2.8; P¼ .007) or CVA (OR, 3.7; P¼ .02),
occurrence of postoperative stroke (OR, 6.3; P< .0001),
need for tracheostomy (OR, 4.2; P ¼ .01), and dialysis
(OR, 5.0; P ¼ .03).
Late Results
The crude mortality rate at last follow-up was 21.6%
(n¼ 156). Variables associated with late mortality are listed
in Table 2. The Kaplan–Meier survival curve generated for
the entire cohort is shown in Figure 1. Cox proportional haz-
ards analysis identified increasing age (P<.0001;HR, 1.05),
preoperative creatinine (P ¼ .005; HR, 1.57), history of
coronary artery bypass grafting (P<.0001, HR, 5.62) or de-
scending aortic replacement (P ¼ .001; HR, 11.14), pro-
longed circulatory arrest time (P ¼ .008; HR, 1.021), and
requirement for postoperative tracheostomy (P ¼ .032;
HR, 3.16) as independent predictors of late mortality. Al-
though not identified as an independent risk factor on mul-
tivariate analysis, type A dissection did have an important
time-dependent effect on mortality (Figure 2). Its primary
effects on mortality seem to be exerted in the early postop-
erative period, but as Figure 2 shows, the survival curves
are relatively parallel thereafter.
Freedom from late aortic reoperation at 10 years was
72.6%, and the actuarial curve is presented in Figure 3,
A. Procedures at reoperation (n ¼ 82) included open (43
patients) or endovascular (11 patients) descending aortic
repair, thoracoabdominal aneurysmectomy (11 patients),
completion arch procedures (4 patients), abdominal aortic
repair (4 patients), and aortic valve or root replacement (8
patients). One patient had a repair for an infected pseudoa-
neurysm at the proximal anastomosis of the ascending graft
and dehiscence of the right coronary button from a previous
Bentall repair. When evaluated by Cox proportional hazards
analysis, independent predictors of late reoperation in-
cluded an elephant trunk procedure at the time of arch
reconstruction (P<.0001; HR, 9.26). The latter was likely
a result of the high frequency (13/42 patients [31%]) in
which the elephant trunk procedure was a required first-
stage operation in anticipation of a predefined second-
stage procedure. In addition, an aortic valve or aortic rootdiovascular Surgery c Volume 141, Number 6 1419
TABLE 2. Univariate predictors of late mortality
Variable Univariate P value
Age <.0001
Male gender .064
History of tobacco use .018
Hypertension .006
Peripheral vascular occlusive disease <.0001
Coronary artery disease .042
Congestive heart failure .005
Status of operation .003
Maximum aortic diameter .018
Preoperative creatinine .009
Prior CABG .002
Prior descending aortic repair .004
Preoperative ejection fraction <.0001
Operation for type A dissection .003
Need for concomitant CABG .009
Cardiopulmonary bypass times <.0001
Myocardial ischemia times <.0001
Cerebral ischemic times .002
Lower body circulatory arrest times <.0001
Postoperative stroke .03
Postoperative need for permanent dialysis .001
Postoperative tracheostomy <.0001
CABG, Coronary artery bypass grafting.
FIGURE 1. Kaplan–Meier survival analysis for the entire cohort. The
12-year survival for the entire cohort is 51.2%  0.5%.
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dently protective against future aortic events (P¼ .003; HR,
0.5). The occurrence of type A dissection did not predict
late reoperation (univariate P ¼ .19). Similarly, Kaplan–
Meier analysis stratified by initial operation for type A dis-
section did not identify time-dependent effects (P ¼ .128),
although the curves crossed early and then separated. This
suggested that longer follow-up with more robust numbers
may suggest otherwise (Figure 3, B).FIGURE 2. Kaplan–Meier survival analysis stratified by presence of type
A aortic dissection. When separated by indication for intervention, the sur-
vival of the group presenting with acute type A aortic dissection is poorer
than that of the group presenting with other pathology. The 10-year survival
for the type A group is 58.0%  0.4% and contrasts with the non–type
A group at 69.1%  0.4% (log rank P ¼ .003).DISCUSSION
The recent shift in aortic surgery toward endovascular
solutions continues to move proximally, with recent work
suggesting a reduction in morbidity for descending aortic
repair with TEVAR when compared with open repair.9,10
As this technology progresses toward the arch and into
the ascending aorta, a contemporary analysis of open arch
reconstruction is appropriate to define a comparative
group against which the newer technology can be
compared and to identify patient populations at high risk
who may benefit from a less-invasive approach. It is in
this setting that we undertook the current analysis, focusing
on the study period that TEVAR was available at the
University of Michigan Cardiovascular Center.
The data in this study suggest that open arch reconstruc-
tion can be performed safely. Early results suggest that the
complications of arch repair (ie, death and stroke) can occur
at rates less than 5%. The rates of these complications in1420 The Journal of Thoracic and Cardiovascular Surour study are comparable to those reported in the contempo-
rary era despite a high frequency of acute type A dissection
(39.3%), reoperative procedures (15.4%), and extended
arch repair (42.7%).11-19 Early mortality was dependent
on traditional factors, such as perfusion and body
circulatory arrest times, but also identified older patients
as a potential group in whom to initially apply
endovascular solutions. In addition, postoperative stroke
was predicted by extent of resection (with resection into
the descending aorta as a surrogate marker) or procedure
for type A dissection. The use of ACP or RCP did notgery c June 2011
FIGURE 3. A, Kaplan–Meier analysis of late aortic events. Freedom from late aortic reoperation at any segment was 72.6% 0.4% at 10 years. Although
risk for late reoperation was not significantly different between type A and non–type A pathologic groups (B, log rank P ¼ .128), examination of the data
suggests that the curves separated early and that more robust patient numbers with longer follow-up may demonstrate a difference.
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benefits of ACP continue to be debated, an alternative
hypothesis for this lack of difference in the current study
may be a selection bias favoring use of ACP in extended
arch resection and preventing prolonged (>60 minutes)
cerebral ischemic times.16-19 Indeed, the mean cerebral
ischemic times were relatively short (mean, 16.6  14.0
minutes; range, 0–67 minutes). When contrasted with the
mean lower body circulatory arrest times of 36.6  15.6
minutes, this suggests that an aggressive strategy of using
ACP in this instance may diminish the risk of stroke. This
is particularly relevant given the classic work by Svensson
and colleagues3 suggesting increasing risk for stroke with
HCA times exceeding 40 minutes. As reported by others,
this suggests moderate hypothermia (temperatures, 22C–
25C) with cerebral perfusion may be well tolerated.
Late results in this study suggest that preoperative fac-
tors, such as age, impaired renal function, and prior coro-
nary artery bypass grafting, predict late mortality and
identify groups of patients whomay be ideal for an endovas-
cular solution. The identification of prolonged lower body
circulatory arrest times is likely a surrogate for pathology
that was more extensive or difficult to reconstruct. Estrera
and colleagues12 have suggested similar results with their
identification of the intraoperative variable of cardiopulmo-
nary bypass times as predictive of late mortality. Late reop-
erations on the aorta were protected by concomitant aortic
valve or root replacement. This was also a surprising finding
and differs when compared with data from Sabik and col-
leagues14 and Estrera and colleagues,12 and thus deserves
validation in future work. A closer evaluation of the actual
reoperative procedures finds that the majority (79.3%) are
repairs of the descending or thoracoabdominal aorta, whichThe Journal of Thoracic and Carmay relate to the higher frequency of aortic dissection
treated in this study when compared with that of Estrera
and colleagues. Indeed, when stratified by operative proce-
dure for type A dissection, freedom from reoperation was
lower in the dissection group. Although not statistically sig-
nificant, examination of the Kaplan–Meier curves reveals
that these lines diverge early and remain separated thereaf-
ter, suggesting that either larger sample size or longer
follow-up may reveal otherwise.
It is important to note that TEVAR was not appropriate
for the majority of patients treated in this study, primarily
because of the pathology treated (eg, type A dissection) or
the anatomic constraints related to the proximity of aortic
valve or arch branch vessels (eg, root, ascending, and prox-
imal arch aneurysm). From 1993 to 2005, TEVAR was typ-
ically performed only in the setting of distal arch fusiform
or saccular aneurysms or type B aortic dissections. Since
2005, the alternatives of hybrid arch debranching with TE-
VAR or, more recently, TEVAR with the ‘‘snorkel’’ branch
vessel technique have been used primarily in patients con-
sidered too high risk for open aortic repair. Despite our
long experiencewith TEVAR at the University ofMichigan,
we have not fully embraced the notion of endovascular
repair with arch debranching as a substitute in all patients
presenting with arch aneurysms. This partly stems from
our positive experience with open repair as reported in
this article. The second and equally important reservation
is based on the unknown long-term durability of TEVAR
in the unfavorable ascending and arch aortic configuration.
Finally, as the Stanford group20 has also suggested in their
analysis of patients presenting with bicuspid aortic valve
and ascending aneurysms, a majority of patients will have
enlargement in the root and proximal ascending aorta,diovascular Surgery c Volume 141, Number 6 1421
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junction, and coronary ostia make TEVAR with debranch-
ing procedures or branched endografts unfeasible with cur-
rent technology. Their work suggests that in identifying an
endovascular solution to the ascending aorta, a valved
conduit addressing the coronary arteries may need to be
considered as an option.
Study Limitations
Limitations of this study include its retrospective nature
over a long study period. Small differences in operative
technique and perioperative care may have affected out-
comes, although this was not borne out after statistical anal-
ysis based on era of operation. Another limitation included
the lack of complete follow-up with regard to secondary
outcome of reoperation. However, the robust sample size
and long interval of the studymay havemitigated the effects
of this limitation.
CONCLUSIONS
We have presented one of the largest series of open repair
of aortic arch pathology reported in the literature. Our data
suggest that this once dreaded clinical scenario can be ad-
dressed with low rates of morbidity and need for reoperation
in the treated segments. As the therapy of aortic disease
evolves into a more endovascular-based approach, certain
subgroups of patients, such as those with advanced age or
impaired renal function, emerge as ideal candidates for
this application of newer technology.
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DrAlberto Pochettino (Philadelphia, Pa). An outstanding pre-
sentation from master surgeons. It is particularly impressive to me
that you have a 100% follow-up. I am somewhat envious of that. I
found as I reviewed the article that you provided to me that your
use of RCP and selective antegrade perfusion was sensible in my
mind and very safe, which led to the outstanding results. I have
a couple of comments.
The first one relates to using the data that you have from this
series as a benchmark against which newer techniques can be
measured. The majority of your reconstruction involved aortic
root reconstruction in what we would call arch hemi or arch total
arches. That group, even with today’s technology, is not amenable,
I don’t think, to hybrid reconstruction. So I think it would make
sense to look at the isolated arches or isolated arches plus descend-
ing reconstruction that you had and use that group, which accounts
for approximately 13% of your patients, as a benchmark against
which the arch hybrid should be compared. Do you have data on
that group?
Dr Patel.We have not separated the analysis out specifically on
that basis, but we appreciate your comments, understanding the
current limitations of endograft technology. However, we do
know that endograft technology is progressing to the ascending
aorta and may soon include ascending and root procedures as
well, and we believe that these data should be compared with
contemporary open surgical procedures, such as that described
here. But we fully understand and appreciate your comments.
Dr Pochettino.My next comment is about aortic dissection. As
you know, I have come to use what has been described as a frozen
elephant trunk in the treatment of acute type A dissection. You
have a large series of patients with type A dissection, and it would
be useful again as a comparison against which we should look atgery c June 2011
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dure and how they fare both in terms of freedom from reoperation
and survival. Do you have data on the DeBakey 1 cohort?
Dr Patel. We did not stratify the analysis based on extent of
dissection. Just having been involved in a few of these procedures,
I can suggest to you that a majority of these patients truly had
dissections that extended throughout the aorta, but unfortunately
I do not have that separate analysis as you have requested.
Dr Pochettino. One last question. I noticed from your article
that you have changed your total arch reconstruction from an is-
land to individual segments, to either all 3 of the vessels or at least
2. Have you noticed a decrease in the stroke rate as you changed
your technique?
Dr Patel. That is a great question. Unfortunately, I did not
separate this out into the island versus the individual bypass graft
technique. We will tell you, as probably other surgeons have de-
scribed, some of the bleeding risks may be less with the individual
bypass technique, and we evolved toward that. My senior partner,
Mike Deeb, evolved toward that when I was a resident in 2001, and
since then we have virtually exclusively used the multibranch
grafts that are available to us.
Dr Pochettino. Outstanding series.
Dr John Ikonomidis (Charleston, SC). Himanshu, congratula-
tions on a beautifully presented study of a large population of aor-
tic arch reconstructions. I have a 2-part question for you. I wonder
if it is really appropriate when one considers stroke rates to group
hemi-arch replacements with total arch replacements, because I
think technically they are 2 different operations. An aortic arch re-
construction involves more manipulation of the great vessels, and
one would expect intuitively that it would be associated with
a higher stroke rate, and therefore including hemi-arches in the
analysis would somewhat buffer that effect. My first question is,
did you separate out hemi-arches from full arches, and what
were the relative stroke rates in those? Related to that, did you in-
clude requirement for total arch replacement in your multivariable
analysis to see if that was an independent predictor of stroke?
Dr Patel.When we analyzed the incidence of stroke, we did in-
clude the extent of resection in that analysis, and as a surrogate,
extension into the descending aorta was identified as an indepen-
dent risk factor for stroke. However, whether we used 1, 2, or 3 by-
passes really did not separate out on univariate or multivariate
analysis as a risk factor for stroke.
I will tell you that in our series, the neuroprotection strategy,
whether it was just isolated RCP or a combination of RCP and
ACP, really did not make a difference whether we saw postopera-
tive stroke or not, and I suspect that it is partly because it is
drowned in the numbers, because the bias obviously is that when
we extended to a total arch repair, we would typically use ACP.
If you look at the cerebral ischemic times that were calculated
out for each patient, the cerebral ischemic time for the entire co-
hort was approximately 15 or 16 minutes, whereas the total lowerThe Journal of Thoracic and Carbody circulatory arrest time was approximately 30 to 35 minutes.
So a significant proportion of patients did have an antegrade cere-
bral approach, and perhaps that may have mitigated the effects of
extended arch reconstruction and its effects on stroke as well.
Dr Ali Khoynezhad (Omaha, Neb). Himanshu, that was an ex-
cellent presentation with great results. A question about a subset
(the patients with type A aortic dissection): Not surprisingly,
they had a higher early mortality, reoperation, and probably
a higher stroke rate. Did you look into different cannulation sites,
such as femoral or axillary cannulation for HCA, and did you find
any difference in outcome of those patients? Also, was there any
difference in outcomes by using transcranial Doppler? I adopted
it early on, and this was before, especially since Dr Safi’s group
showed improvement of outcomes by utility intraoperative modi-
fication of the cannulation site when patients went on or came off
pump to reduce cerebral malperfusion.
Dr Patel.We typically do not use other adjunctivemaneuvers to
determine whether there are changes in cerebral perfusion, such as
cerebral oximetry and so on. The cannulation strategy in acute type
A dissection evolved throughout the study. The majority of
patients early on, and I would say until about 2005 or so, were
cannulated usually through femoral access in the setting of acute
type A dissection. In the setting of elective aneurysm or urgent an-
eurysm repair, if the pathology allowed it, meaning if it wasn’t
very calcified or so on, we would usually cannulate the ascending
aorta and go on bypass that way. We have done axillary perfusion
in a smaller number of patients who presented with an acute type
A dissection, but that is more recently, within the last 3 or 4 years.
I unfortunately don’t have the data separating it out on the basis of
cannulation site as a marker for stroke, but I do understand that
there has been literature prescribing axillary approaches to reduce
the risk of stroke.
Dr Anthony Estrera (Houston, Tex). Himanshu, a nice job. I
think one of the deceptive things when you present your data is
your late reintervention rate, because the reality is howmanyof these
patients you had to reintervene for the arch portion of the graft, be-
cause if you are going to compare this with endovascular therapies,
one of the main limitations with endovascular therapies are all these
endoleaks related to the graft. The reality ismost of your late reinter-
ventions are related to progression of disease distal to your arch
graft, and I would presume that your arch repairs are very durable.
So if you could present some of that data, I think it would be helpful
when you are comparing it as a contemporary series.
DrPatel. If I remember correctly in the analysis, theremay have
been only 1 person who underwent reoperation in this entire series
that we know of who had an anastomotic issue, and that was a pa-
tientwho actually came inwith an infected proximal suture line and
developed a pseudoaneurysm requiring a root and partial ascending
reconstruction. But you are absolutely correct, the majority of late
reoperations are secondary to progression of disease in other aortic
segments, not the treated aortic segment, as you would expect.diovascular Surgery c Volume 141, Number 6 1423
